Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Eur J Clin Pharmacol. 2021 Oct;77(10):1443-1452. doi: 10.1007/s00228-021-03131-y. Epub 2021 Apr 7.
Cerebral haemorrhage is a life-threatening event with various causes including adverse drug reactions (ADRs). Several methods have been proposed for the causality assessment of ADRs, but none specific for cerebral haemorrhage. The purpose of this study was to develop an algorithm for causality assessment between drugs and fatal cerebral haemorrhage, based on the analysis of data from the Japanese Adverse Drug Event Report (JADER) database and literature review.
All fatal ADRs reported in the JADER database between April 2004 and March 2020 were searched, and literature on drug-related cerebral haemorrhage or general causality assessment was reviewed to summarise the information on causality between cerebral haemorrhage and ADRs.
Of the 50,095 cases identified in the JADER database, cerebral haemorrhage was the fifth most reported cause of fatal ADRs, but the causality of >80% of the events was published as 'Unassessable'. The literature review identified articles on drug-related cerebral haemorrhage and causality assessment methods in general. Based on these articles, information on five categories (temporal relationship, previous knowledge about the relationship between drug action and ADRs, alternative aetiological candidate, appropriateness of drug use, and the relationship between death and ADRs) was determined for causality assessment between a suspected drug and fatal cerebral haemorrhage; a new algorithm was created using this information.
In this study, the information considered necessary for causality assessment between drugs and fatal cerebral haemorrhage was reviewed and an assessment algorithm was developed. Future studies are needed to validate the usefulness of this method.
脑出血是一种危及生命的事件,其病因包括药物不良反应(ADR)。已经提出了几种用于评估 ADR 因果关系的方法,但没有专门针对脑出血的方法。本研究旨在基于日本药物不良反应报告(JADER)数据库的数据和文献回顾,开发一种用于评估药物与致命性脑出血之间因果关系的算法。
在 JADER 数据库中搜索了 2004 年 4 月至 2020 年 3 月期间报告的所有致命性 ADR,并对与药物相关的脑出血或一般因果关系评估的文献进行了综述,以总结脑出血与 ADR 之间因果关系的信息。
在 JADER 数据库中确定的 50095 例病例中,脑出血是报告的第五大致命性 ADR 原因,但超过 80%的事件的因果关系被发表为“无法评估”。文献综述确定了与药物相关的脑出血和一般因果关系评估方法的文章。基于这些文章,确定了用于评估可疑药物与致命性脑出血之间因果关系的五个类别(时间关系、药物作用与 ADR 之间关系的先前知识、替代病因候选物、药物使用的适当性和死亡与 ADR 之间的关系);使用这些信息创建了一个新的算法。
在本研究中,对评估药物与致命性脑出血之间因果关系所需的信息进行了回顾,并开发了一种评估算法。未来需要进一步的研究来验证该方法的有效性。